{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:37:15Z","timestamp":1784309835530,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308723\/2013-9"],"award-info":[{"award-number":["308723\/2013-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior"},{"name":"NENASC Project (PRONEX-FAPESC\/CNPq)","award":["1262\/2012-9"],"award-info":[{"award-number":["1262\/2012-9"]}]},{"DOI":"10.13039\/501100001675","name":"International Brain Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00210-017-1446-4","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T06:38:48Z","timestamp":1512715128000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evidence for the involvement of opioid system in the antidepressant-like effect of ascorbic acid"],"prefix":"10.1007","volume":"391","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-9280","authenticated-orcid":false,"given":"Morgana","family":"Moretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian B.","family":"Neis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo B.","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila B.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4172\/2161-0487.1000131","volume":"4","author":"SG Aburawi","year":"2014","unstructured":"Aburawi SG, Ghambirlou FA, Attumi AA, Altubuly RA, Kara AA (2014) Effect of ascorbic acid on mental depression drug therapy: clinical study. J Psychol Psychother 4:131","journal-title":"J Psychol Psychother"},{"issue":"1","key":"1446_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-12-31","volume":"12","author":"M Amr","year":"2013","unstructured":"Amr M, El-Mogy A, Shams T, Vieira K, Lakhan SE (2013) Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. Nutr J 12(1):31. \nhttps:\/\/doi.org\/10.1186\/1475-2891-12-31","journal-title":"Nutr J"},{"issue":"2","key":"1446_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137\u2013151. \nhttps:\/\/doi.org\/10.1038\/nrn1846","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1446_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.pnpbp.2009.02.003","volume":"33","author":"RW Binfare","year":"2009","unstructured":"Binfare RW, Rosa AO, Lobato KR, Santos AR, Rodrigues ALS (2009) Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuro-Psychopharmacol Biol Psychiatry 33(3):530\u2013540. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2009.02.003","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"1446_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/da.22505","volume":"33","author":"WV Bobo","year":"2016","unstructured":"Bobo WV, Voort JL, Croarkin PE, Leung JG, Tye SJ, Frye MA (2016) Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice. Depress Anxiety 33(8):698\u2013710. \nhttps:\/\/doi.org\/10.1002\/da.22505","journal-title":"Depress Anxiety"},{"issue":"12","key":"1446_CR6","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1016\/j.peptides.2006.07.011","volume":"27","author":"RJ Bodnar","year":"2006","unstructured":"Bodnar RJ, Klein GE (2006) Endogenous opiates and behavior: 2005. Peptides 27(12):3391\u20133478. \nhttps:\/\/doi.org\/10.1016\/j.peptides.2006.07.011","journal-title":"Peptides"},{"issue":"1","key":"1446_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hup.178","volume":"16","author":"M Bourin","year":"2001","unstructured":"Bourin M, Fiocco AJ, Clenet F (2001) How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol 16(1):9\u201321. \nhttps:\/\/doi.org\/10.1002\/hup.178","journal-title":"Hum Psychopharmacol"},{"issue":"1\u20133","key":"1446_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","volume":"598","author":"S Brocardo Pde","year":"2008","unstructured":"Brocardo Pde S, Budni J, Lobato KR, Kaster MP, Rodrigues ALS (2008) Antidepressant-like effect of folic acid: involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur J Pharmacol 598(1\u20133):37\u201342. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2008.08.033","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1446_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbr.2009.01.004","volume":"200","author":"PS Brocardo","year":"2009","unstructured":"Brocardo PS, Budni J, Lobato KR, Santos AR, Rodrigues AL (2009) Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test. Behav Brain Res 200(1):122\u2013127. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2009.01.004","journal-title":"Behav Brain Res"},{"issue":"4","key":"1446_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0006-3223(02)01329-X","volume":"52","author":"S Brody","year":"2002","unstructured":"Brody S (2002) High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial. Biol Psychiatry 52(4):371\u2013374. \nhttps:\/\/doi.org\/10.1016\/S0006-3223(02)01329-X","journal-title":"Biol Psychiatry"},{"issue":"2\u20133","key":"1446_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejphar.2011.02.039","volume":"658","author":"CA Bruning","year":"2011","unstructured":"Bruning CA, Souza AC, Gai BM, Zeni G, Nogueira CW (2011) Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems. Eur J Pharmacol 658(2\u20133):145\u2013149. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2011.02.039","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1446_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.npp.1300875","volume":"31","author":"AL Curtis","year":"2006","unstructured":"Curtis AL, Bethea T, Valentino RJ (2006) Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 31(3):544\u2013554. \nhttps:\/\/doi.org\/10.1038\/sj.npp.1300875","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1446_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/0019-5545.102424","volume":"54","author":"M Gautam","year":"2012","unstructured":"Gautam M, Agrawal M, Gautam M, Sharma P, Gautam AS, Gautam S (2012) Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry 54(3):244\u2013247. \nhttps:\/\/doi.org\/10.4103\/0019-5545.102424","journal-title":"Indian J Psychiatry"},{"issue":"6","key":"1446_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","volume":"46","author":"FE Harrison","year":"2009","unstructured":"Harrison FE, May JM (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 46(6):719\u2013730. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.12.018","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1446_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/mp.2014.185","volume":"20","author":"DT Hsu","year":"2015","unstructured":"Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Walker SJ, Mickey BJ, Koeppe RA, Langenecker SA, Zubieta JK (2015) It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry 20(2):193\u2013200. \nhttps:\/\/doi.org\/10.1038\/mp.2014.185","journal-title":"Mol Psychiatry"},{"issue":"1\u20133","key":"1446_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2007.08.026","volume":"576","author":"MP Kaster","year":"2007","unstructured":"Kaster MP, Budni J, Santos AR, Rodrigues AL (2007) Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test. Eur J Pharmacol 576(1\u20133):91\u201398. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2007.08.026","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1446_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1734-1140(12)70865-4","volume":"64","author":"MP Kaster","year":"2012","unstructured":"Kaster MP, Machado DG, Santos AR, Rodrigues AL (2012) Involvement of NMDA receptors in the antidepressant-like action of adenosine. Pharmacol Rep 64(3):706\u2013713. \nhttps:\/\/doi.org\/10.1016\/S1734-1140(12)70865-4","journal-title":"Pharmacol Rep"},{"issue":"6","key":"1446_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1179\/135100003225003393","volume":"8","author":"SD Khanzode","year":"2003","unstructured":"Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R (2003) Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8(6):365\u2013370. \nhttps:\/\/doi.org\/10.1179\/135100003225003393","journal-title":"Redox Rep"},{"issue":"3","key":"1446_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/endo-105-3-812","volume":"105","author":"JC Mevel Le","year":"1979","unstructured":"Le Mevel JC, Abitbol S, Beraud G, Maniey J (1979) Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats. Endocrinology 105(3):812\u2013817. \nhttps:\/\/doi.org\/10.1210\/endo-105-3-812","journal-title":"Endocrinology"},{"issue":"7","key":"1446_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","volume":"11","author":"A Mansour","year":"1988","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11(7):308\u2013314. \nhttps:\/\/doi.org\/10.1016\/0166-2236(88)90093-8","journal-title":"Trends Neurosci"},{"issue":"3","key":"1446_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0165-0173(99)00020-X","volume":"30","author":"J Mao","year":"1999","unstructured":"Mao J (1999) NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain research. Brain Res Rev 30(3):289\u2013304. \nhttps:\/\/doi.org\/10.1016\/S0165-0173(99)00020-X","journal-title":"Brain Res Rev"},{"issue":"4","key":"1446_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1365-2044.2000.01463.x","volume":"55","author":"M Maze","year":"2000","unstructured":"Maze M, Fujinaga M (2000) Recent advances in understanding the actions and toxicity of nitrous oxide. Anaesthesia 55(4):311\u2013314. \nhttps:\/\/doi.org\/10.1046\/j.1365-2044.2000.01463.x","journal-title":"Anaesthesia"},{"issue":"1","key":"1446_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12031-012-9892-4","volume":"49","author":"M Moretti","year":"2013","unstructured":"Moretti M, Budni J, Dos Santos DB, Antunes A, Daufenbach JF, Manosso LM, Farina M, Rodrigues ALS (2013) Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice. J Mol Neurosci 49(1):68\u201379. \nhttps:\/\/doi.org\/10.1007\/s12031-012-9892-4","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1446_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpsychires.2013.10.014","volume":"48","author":"M Moretti","year":"2014","unstructured":"Moretti M, Budni J, Freitas AE, Rosa PB, Rodrigues ALS (2014) Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway. J Psychiatr Res 48(1):16\u201324. \nhttps:\/\/doi.org\/10.1016\/j.jpsychires.2013.10.014","journal-title":"J Psychiatr Res"},{"issue":"6","key":"1446_CR25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.euroneuro.2015.03.006","volume":"25","author":"M Moretti","year":"2015","unstructured":"Moretti M, Budni J, Freitas AE, Neis VB, Ribeiro CM, de Oliveira Balen G, Rieger DK, Leal RB, Rodrigues ALS (2015) TNF-\u03b1-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment. Eur Neuropsychopharmacol 25(6):902\u2013912. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2015.03.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"1446_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jnutbio.2016.09.004","volume":"38","author":"M Moretti","year":"2016","unstructured":"Moretti M, Budni J, Ribeiro CM, Rieger DK, Leal RB, Rodrigues ALS (2016) Subchronic administration of ascorbic acid elicits antidepressant-like effect and modulates cell survival signaling pathways in mice. J Nutr Biochem 38:50\u201356. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2016.09.004","journal-title":"J Nutr Biochem"},{"issue":"1\u20133","key":"1446_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2012.04.041","volume":"687","author":"M Moretti","year":"2012","unstructured":"Moretti M, Budni J, Ribeiro CM, Rodrigues ALS (2012a) Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test. Eur J Pharmacol 687(1\u20133):21\u201327. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2012.04.041","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1446_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","volume":"46","author":"M Moretti","year":"2012","unstructured":"Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni J, de Freitas AE, Farina M, Rodrigues ALS (2012b) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 46(3):331\u2013340. \nhttps:\/\/doi.org\/10.1016\/j.jpsychires.2011.11.009","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1446_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","volume":"225","author":"M Moretti","year":"2011","unstructured":"Moretti M, Freitas AE, Budni J, Fernandes SC, Balen Gde O, Rodrigues ALS (2011) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test. Behav Brain Res 225(1):328\u2013333. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2011.07.024","journal-title":"Behav Brain Res"},{"key":"1446_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","volume":"261","author":"VB Neis","year":"2014","unstructured":"Neis VB, Manosso LM, Moretti M, Freitas AE, Daufenbach J, Rodrigues ALS (2014) Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration. Behav Brain Res 261:336\u2013344. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2013.12.038","journal-title":"Behav Brain Res"},{"key":"1446_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","volume":"130","author":"VB Neis","year":"2015","unstructured":"Neis VB, Moretti M, Manosso LM, Lopes MW, Leal RB, Rodrigues ALS (2015) Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice. Pharmacol Biochem Behav 130:9\u201314. \nhttps:\/\/doi.org\/10.1016\/j.pbb.2014.12.009","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"1446_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59(12):1151\u20131159. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2005.09.018","journal-title":"Biol Psychiatry"},{"issue":"8174","key":"1446_CR33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(80)90875-2","volume":"1","author":"D Pickar","year":"1980","unstructured":"Pickar D, Cutler NR, Naber D, Post RM, Pert CB, Bunney WE Jr (1980) Plasma opioid activity in manic-depressive illness. Lancet 1(8174):937","journal-title":"Lancet"},{"issue":"6","key":"1446_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0301-0082(94)90052-3","volume":"43","author":"GV Rebec","year":"1994","unstructured":"Rebec GV, Pierce RC (1994) A vitamin as neuromodulator\u2014ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol 43(6):537\u2013565. \nhttps:\/\/doi.org\/10.1016\/0301-0082(94)90052-3","journal-title":"Prog Neurobiol"},{"issue":"5","key":"1446_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","volume":"23","author":"ME Rice","year":"2000","unstructured":"Rice ME (2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 23(5):209\u2013216. \nhttps:\/\/doi.org\/10.1016\/S0166-2236(99)01543-X","journal-title":"Trends Neurosci"},{"issue":"5","key":"1446_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.pharep.2016.05.010","volume":"68","author":"PB Rosa","year":"2016","unstructured":"Rosa PB, Neis VB, Ribeiro CM, Moretti M, Rodrigues ALS (2016) Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors. Pharmacol Rep 68(5):996\u20131001. \nhttps:\/\/doi.org\/10.1016\/j.pharep.2016.05.010","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1446_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13063-015-0609-1","volume":"16","author":"A Sahraian","year":"2015","unstructured":"Sahraian A, Ghanizadeh A, Kazemeini F (2015) Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial. Trials 16(1):94\u2013102. \nhttps:\/\/doi.org\/10.1186\/s13063-015-0609-1","journal-title":"Trials"},{"issue":"1\u20132","key":"1446_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1385\/JMN:18:1-2:143","volume":"18","author":"S Schreiber","year":"2002","unstructured":"Schreiber S, Bleich A, Pick CG (2002) Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects\u2014a possible opioid involvement in severe depression? J Mol Neurosci 18(1\u20132):143\u2013149. \nhttps:\/\/doi.org\/10.1385\/JMN:18:1-2:143","journal-title":"J Mol Neurosci"},{"issue":"6","key":"1446_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2826.2004.01195.x","volume":"16","author":"JV Seale","year":"2004","unstructured":"Seale JV, Wood SA, Atkinson HC, Bate E, Lightman SL, Ingram CD, Jessop DS, Harbuz MS (2004) Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J Neuroendocrinol 16(6):516\u2013524. \nhttps:\/\/doi.org\/10.1111\/j.1365-2826.2004.01195.x","journal-title":"J Neuroendocrinol"},{"key":"1446_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajp.2017.01.015","volume":"26","author":"CN Stanciu","year":"2017","unstructured":"Stanciu CN, Glass OM, Penders TM (2017) Use of buprenorphine in treatment of refractory depression\u2014a review of current literature. Asian J Psychiatr 26:94\u201398. \nhttps:\/\/doi.org\/10.1016\/j.ajp.2017.01.015","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"1446_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/Bf00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test\u2014a new method for screening antidepressants in mice. Psychopharmacology 85(3):367\u2013370. \nhttps:\/\/doi.org\/10.1007\/Bf00428203","journal-title":"Psychopharmacology"},{"issue":"12","key":"1446_CR42","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1176\/ajp.156.12.2017","volume":"156","author":"AL Stoll","year":"1999","unstructured":"Stoll AL, Rueter S (1999) Treatment augmentation with opiates in severe and refractory major depression. Am J Psychiatry 156(12):2017. \nhttps:\/\/doi.org\/10.1176\/ajp.156.12.2017","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1446_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nat Rev Neurosci 2(5):343\u2013351. \nhttps:\/\/doi.org\/10.1038\/35072566","journal-title":"Nat Rev Neurosci"},{"key":"1446_CR44","doi-asserted-by":"publisher","first-page":"175619","DOI":"10.1155\/2012\/175619","volume":"2012","author":"C Yang","year":"2012","unstructured":"Yang C, Li WY, Yu HY, Gao ZQ, Liu XL, Zhou ZQ, Yang JJ (2012a) Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex. J Biomed Biotechnol 2012:175619\u2013175616. \nhttps:\/\/doi.org\/10.1155\/2012\/175619","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"1446_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11684-012-0226-2","volume":"6","author":"C Yang","year":"2012","unstructured":"Yang C, Li X, Wang N, Xu S, Yang J, Zhou Z (2012b) Tramadol reinforces antidepressant effects of ketamine with increased levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in rat hippocampus. Front Med 6(4):411\u2013415. \nhttps:\/\/doi.org\/10.1007\/s11684-012-0226-2","journal-title":"Front Med"},{"issue":"3","key":"1446_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","volume":"381","author":"AD Zomkowski","year":"2005","unstructured":"Zomkowski AD, Santos AR, Rodrigues ALS (2005) Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 381(3):279\u2013283. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2005.02.026","journal-title":"Neurosci Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1446-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T01:57:41Z","timestamp":1516586261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1446-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1446-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}